NSCLC - Non Small Cell Lung Cancer Now Closed
KEYNOTE-715-05 / MK-3475-715 - Hosted By elie
Save
Bookmark
Print
| Sponsor Name | |
| Tumor Site | NSCLC - Non Small Cell Lung Cancer |
| Disease Stage | Stage IV |
| Clinical Status | Advanced Disease 1st Line |
| Phase | Phase III |
| Intervention / Treatment | Pembrolizumab + Epacadostat +/- Chemo vs Pembrolizumab + Chemo + Placebo |
| Research Site | St. Mary's Hospital, Montreal, QC |
| Investigator | Dr Adrian Langleben |
| Telephone Number | +1 (514) 345-3511 |
| Study Start Date | October 26, 2017 |
| Study End Date | September 1, 2021 |
| Trial Status | Recruitment |
